Satoshi Ito
National Institutes of Health
4 Papers
89 Citations
Satoshi Ito is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Adjuvant & Nasal administration. The author has an hindex of 4, co-authored 4 publications. Previous affiliations of Satoshi Ito include Tokyo University of Science.
Chat about Author
Papers
Synthetic Double-Stranded RNA Poly(I:C) Combined with Mucosal Vaccine Protects against Influenza Virus Infection
Takeshi Ichinohe,Izumi Watanabe,Izumi Watanabe,Satoshi Ito,Satoshi Ito,Hideki Fujii,Masami Moriyama,Shinichi Tamura,Hidehiro Takahashi,Hirofumi Sawa,Joe Chiba,Takeshi Kurata,Tetsutaro Sata,Hideki Hasegawa +13 more
TL;DR: It is proposed that poly(I:C) is a new effective intranasal adjuvant for influenza virus vaccine.
294
Protection against influenza virus infection by intranasal administration of hemagglutinin vaccine with chitin microparticles as an adjuvant.
Hideki Hasegawa,Takeshi Ichinohe,Takeshi Ichinohe,Peter Strong,Izumi Watanabe,Izumi Watanabe,Satoshi Ito,Satoshi Ito,Shinichi Tamura,Hidehiro Takahashi,Hirofumi Sawa,Joe Chiba,Takeshi Kurata,Tetsutaro Sata +13 more
TL;DR: It is suggested that CMP provide a safe and effective adjuvant for nasal vaccination with inactivated influenza vaccine.
63
Protection against influenza virus infection by intranasal administration of C3d-fused hemagglutinin.
Izumi Watanabe,Ted M. Ross,Shinichi Tamura,Takeshi Ichinohe,Takeshi Ichinohe,Satoshi Ito,Satoshi Ito,Hidehiro Takahashi,Hirofumi Sawa,Joe Chiba,Takeshi Kurata,Tetsutaro Sata,Hideki Hasegawa +12 more
TL;DR: C3d fused to the influenza HA antigen is an effective and safe tool for mucosal vaccination in the influenza-BALB/c mouse model and provides complete protection against the influenza virus challenge.
60
Protection against influenza virus infection by intranasal vaccine with surf clam microparticles (SMP) as an adjuvant.
Takeshi Ichinohe,Takeshi Ichinohe,Izumi Watanabe,Izumi Watanabe,Eriko Tao,Satoshi Ito,Satoshi Ito,Akira Kawaguchi,Akira Kawaguchi,Shin-ichi Tamura,Hidehiro Takahashi,Hirofumi Sawa,Masami Moriyama,Joe Chiba,Katsuhiro Komase,Yujiro Suzuki,Takeshi Kurata,Tetsutaro Sata,Hideki Hasegawa +18 more
TL;DR: The present study demonstrated the effectiveness of surf clam microparticles (SMP) derived from natural surf clams as an adjuvant for an intranasal influenza vaccine, suggesting that SMP adjuvanted vaccine can confer cross‐protection against variant influenza viruses.
31